Role of probiotics in patients with Helicobacter pylori infection (Q34711908)

4 August 2017

1 reference

title

Role of probiotics in patients with Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

4 August 2017

0 references

0 references

1 reference

7

Giovanni Gasbarrini

1 reference

4 August 2017

8

Antonio Gasbarrini

1 reference

4 August 2017

Francesco Franceschi

1

1 reference

4 August 2017

Alessia Cazzato

2

1 reference

4 August 2017

Enrico C Nista

3

1 reference

4 August 2017

Emidio Scarpellini

4

1 reference

4 August 2017

Davide Roccarina

5

1 reference

4 August 2017

Giovanni Gigante

6

1 reference

4 August 2017

language of work or name

1 reference

1 November 2007

1 reference

4 August 2017

1 reference

4 August 2017

12 Suppl 2

1 reference

4 August 2017

59-63

1 reference

Probiotics in human medicine

4 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00565.X

10.1111/J.1523-5378.2007.00565.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference